DE69314950T2 - Okulaerdarreichungsform und verfahren zu ihrer herstellung - Google Patents
Okulaerdarreichungsform und verfahren zu ihrer herstellungInfo
- Publication number
- DE69314950T2 DE69314950T2 DE69314950T DE69314950T DE69314950T2 DE 69314950 T2 DE69314950 T2 DE 69314950T2 DE 69314950 T DE69314950 T DE 69314950T DE 69314950 T DE69314950 T DE 69314950T DE 69314950 T2 DE69314950 T2 DE 69314950T2
- Authority
- DE
- Germany
- Prior art keywords
- manufacture
- dosage form
- ocular dosage
- ocular
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9205514A FR2690846B1 (fr) | 1992-05-05 | 1992-05-05 | Forme galenique pour administration oculaire et procede de preparation. |
PCT/FR1993/000433 WO1993021901A1 (fr) | 1992-05-05 | 1993-05-05 | Forme galenique pour administration oculaire et procede de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69314950D1 DE69314950D1 (de) | 1997-12-04 |
DE69314950T2 true DE69314950T2 (de) | 1998-04-16 |
Family
ID=9429535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69314950T Expired - Lifetime DE69314950T2 (de) | 1992-05-05 | 1993-05-05 | Okulaerdarreichungsform und verfahren zu ihrer herstellung |
Country Status (8)
Country | Link |
---|---|
US (1) | US5766619A (de) |
EP (1) | EP0639069B1 (de) |
JP (1) | JP3208568B2 (de) |
KR (1) | KR100206481B1 (de) |
DE (1) | DE69314950T2 (de) |
ES (1) | ES2109493T3 (de) |
FR (1) | FR2690846B1 (de) |
WO (1) | WO1993021901A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19511322C2 (de) | 1995-03-28 | 1999-09-02 | Mann Gerhard Chem Pharm Fab | Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung |
EP1154691A4 (de) * | 1999-01-05 | 2004-07-07 | Massachusetts Eye & Ear Infirm | Gezielte transsklerale gesteuerte wirkstoffabgabe an die retina und choroidae |
US7943162B2 (en) * | 1999-10-21 | 2011-05-17 | Alcon, Inc. | Drug delivery device |
PT1221918E (pt) | 1999-10-21 | 2005-06-30 | Alcon Inc | Administracao de drogas sub-tenon |
US6416777B1 (en) | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
CN1292721C (zh) | 1999-10-21 | 2007-01-03 | 爱尔康公司 | 药物释放装置 |
WO2002089767A1 (en) | 2001-05-03 | 2002-11-14 | Massachusetts Eye And Ear Infirmary | Implantable drug delivery device and use thereof |
WO2003009784A1 (en) * | 2001-07-23 | 2003-02-06 | Alcon, Inc. | Ophthalmic drug delivery device |
CN1203814C (zh) | 2001-07-23 | 2005-06-01 | 爱尔康公司 | 眼部药物输送装置 |
WO2003092665A2 (en) * | 2002-05-02 | 2003-11-13 | Massachusetts Eye And Ear Infirmary | Ocular drug delivery systems and use thereof |
WO2004073551A2 (en) * | 2003-02-18 | 2004-09-02 | Massachusetts Eye And Ear Infirmary | Transscleral drug delivery device and related methods |
US7585517B2 (en) * | 2003-09-18 | 2009-09-08 | Macusight, Inc. | Transscleral delivery |
DK1848431T3 (en) * | 2005-02-09 | 2016-04-18 | Santen Pharmaceutical Co Ltd | LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
BRPI0615962A2 (pt) | 2005-07-27 | 2011-05-31 | Univ Florida | uso de um composto selecionado do grupo que consiste em um inibidor proteassomal, um inibidor de autofagia, um inibidor lisossomal, um inibidor do trasporte de proteìna do er ao golgi, um inibidor de chaperonina hsp90, um ativador da resposta a choque térmico, um inibidor de glicosidade, e um inibidor de histona deacetilase, uso de 11-cis-retinal ou 9-cis-retinal e um composto selecionado do grupo que consiste em um inibidor proteassomal, um inibidor de autofagia, um inibidor lissosomal, um inibidor do transporte de proteìna do er ao golgi, um inibidor de chaperonina hsp90, um ativador de resposta a choque térmico, um inibidor de glicosidase, e um inibidor de histona deacetilase, método para aumentar a quantidade de um conformação bioquimicamente funcional de uma proteìna em uma célula, composição farmacêutica para o tratamento de um pcd ocular, composição farmacêutica para o tratamento de retinite pigmentosa, kit para o tratamento de um pcd ocular, kit para o tratamento de retinite pigmentosa, método para a identificação de um composto útil para o tratamento de um indivìduo que tem um pcd ocular, método para a identificação de um composto útil para o tratamento de um indivìduo que tem retinite pigmentosa, uso de um inibidor proteassomal ou um inibidor de autofagia e método para a produção de uma proteìna recombinante em uma conformação bioquimicamente funcional |
CA2617040A1 (en) * | 2005-07-29 | 2007-02-01 | Santen Pharmaceutical Co., Ltd. | Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
EA016227B1 (ru) | 2005-11-29 | 2012-03-30 | Смитклайн Бичем Корпорейшн | Способ лечения офтальмологических неоваскулярных расстройств |
JP5528708B2 (ja) | 2006-02-09 | 2014-06-25 | 参天製薬株式会社 | 安定な製剤ならびにそれらを調製および使用する方法 |
CN101443004B (zh) | 2006-03-23 | 2013-03-06 | 参天制药株式会社 | 用于与血管通透性有关的疾病或病症的制剂 |
US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
US8632511B2 (en) | 2009-05-06 | 2014-01-21 | Alcon Research, Ltd. | Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device |
IN2012DN00352A (de) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
WO2011039648A1 (en) | 2009-09-30 | 2011-04-07 | Glaxo Wellcome Manufacturing Pte Ltd. | Methods of administration and treatment |
US8177747B2 (en) | 2009-12-22 | 2012-05-15 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
US9133082B2 (en) | 2011-06-14 | 2015-09-15 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
US9499464B2 (en) | 2011-10-19 | 2016-11-22 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
EP2785346A4 (de) | 2011-11-30 | 2015-04-29 | Bikam Pharmaceuticals Inc | Opsinbindende liganden, zusammensetzungen damit und anwendungsverfahren dafür |
AU2012346537A1 (en) | 2011-12-01 | 2014-07-17 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
CN109549922B (zh) * | 2018-12-27 | 2021-04-20 | 湖北远大天天明制药有限公司 | 一种托吡卡胺眼用组合物及其制备方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3630200A (en) * | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
SE352811B (de) * | 1971-06-04 | 1973-01-15 | Pharmacia Ab | |
US3986510A (en) * | 1971-09-09 | 1976-10-19 | Alza Corporation | Bioerodible ocular device |
US3828777A (en) * | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
-
1992
- 1992-05-05 FR FR9205514A patent/FR2690846B1/fr not_active Expired - Lifetime
-
1993
- 1993-05-04 US US08/331,603 patent/US5766619A/en not_active Expired - Lifetime
- 1993-05-05 EP EP93910086A patent/EP0639069B1/de not_active Expired - Lifetime
- 1993-05-05 DE DE69314950T patent/DE69314950T2/de not_active Expired - Lifetime
- 1993-05-05 WO PCT/FR1993/000433 patent/WO1993021901A1/fr active IP Right Grant
- 1993-05-05 ES ES93910086T patent/ES2109493T3/es not_active Expired - Lifetime
- 1993-05-05 JP JP51901293A patent/JP3208568B2/ja not_active Expired - Fee Related
-
1994
- 1994-11-04 KR KR1019940703939A patent/KR100206481B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2109493T3 (es) | 1998-01-16 |
FR2690846A1 (fr) | 1993-11-12 |
EP0639069B1 (de) | 1997-10-29 |
JP3208568B2 (ja) | 2001-09-17 |
KR950701214A (ko) | 1995-03-23 |
JPH07506356A (ja) | 1995-07-13 |
EP0639069A1 (de) | 1995-02-22 |
US5766619A (en) | 1998-06-16 |
KR100206481B1 (en) | 1999-07-01 |
FR2690846B1 (fr) | 1995-07-07 |
WO1993021901A1 (fr) | 1993-11-11 |
DE69314950D1 (de) | 1997-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69314950T2 (de) | Okulaerdarreichungsform und verfahren zu ihrer herstellung | |
DE59606535D1 (de) | Furnacerusse und Verfahren zu ihrer Herstellung | |
DE69327743T2 (de) | Sekundärbatterie und Verfahren zu ihrer Herstellung | |
DE69310402D1 (de) | Beschichtungszusammensetzung und Verfahren zu ihrer Herstellung | |
DE69411604D1 (de) | Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung | |
DE69306615D1 (de) | Verbundwalze und Verfahren zu ihrer Herstellung | |
DE69127949D1 (de) | Thyristor und Verfahren zu dessen Herstellung | |
DE69216772T2 (de) | Medizinische Behälter und Verfahren zu ihrer Herstellung | |
DE69423082T2 (de) | Supraleiter und Verfahren zu dessen Herstellung | |
ATE220666T1 (de) | 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung | |
DE69301771D1 (de) | T-Butyl-R-(-)-4-cyano-3-hydroxybutyrat und Verfahren zu seiner Herstellung | |
DE69106627T2 (de) | Oligohexafluorpropylenverbindungen und Verfahren zu ihrer Herstellung. | |
DE69114420T2 (de) | Organozyklosiloxane und Verfahren zu ihrer Herstellung. | |
DE69306279T2 (de) | 3-Aryl-Glycidsäureester und Verfahren zu ihrer Herstellung | |
DE69017091D1 (de) | Cyclomalto-oligosaccharidderivate und Verfahren zu ihrer Herstellung. | |
DE59206999D1 (de) | Oxadimethacryl-Verbindungen und Verfahren zu ihrer Herstellung | |
DE69227419D1 (de) | Cermet-Elektrode und Verfahren zu ihrer Herstellung | |
DE69212920D1 (de) | Oligohexafluoropropylenverbindungen und Verfahren zu ihrer Herstellung | |
DE68914500T2 (de) | Alkylarylsulfone und Verfahren zu ihrer Herstellung. | |
ATA123792A (de) | Artilleriegranate und verfahren zu ihrer herstellung | |
DE59304565D1 (de) | 2-Methyl-3-chlorpropyl-cyclohexyldialkoxysilane und Verfahren zu ihrer Herstellung | |
DE69326440D1 (de) | Prothese und Verfahren zu ihrer Herstellung | |
DE69406183T2 (de) | Jodvitamin-D-Verbindungen und Verfahren zu ihrer Herstellung | |
DE69606662D1 (de) | Dianilinoglutacondialdehyd-Verbindungen und Verfahren zu ihrer Herstellung | |
DE68910733T2 (de) | Perfluordiaziridine und Verfahren zu ihrer Herstellung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: L' UNIVERSITE D'AUVERGNE ETABLISSEMENT PUBLIC , FR |
|
8381 | Inventor (new situation) |
Inventor name: AIACHE, JEAN-MARC, CLERMONT-FERRAND, FR Inventor name: SERPIN, GILBERT, CLERMONT-FERRAND, FR |